Bob Hoban writes…

As I’ve touched on before, in 2019 the World Health Organization (WHO) made six recommendations for changing the way that cannabis and its derivatives should be scheduled in the 1961 Single Convention on Narcotic Drugs and the subsequent 1971 Convention on Psychotropic Substances.

In early October 2020, there was a gathering in Vienna, Austria, home of the U.N. Commission on Narcotic Drugs. The WHO’s recommended changes were discussed and U.S. State Department attorney Patt Prugh offered America’s formal position on these issues. It was less than favorable.

In short, the U.S disagreed with four of the six WHO recommendations, largely because these changes would “introduce legal ambiguities and contradictions that would undermine effective drug control, and at worst they could result in the exclusion of control of all THC derived from cannabis cultivated for industrial purposes and THC derived from leaves separated from the cannabis plant,” Prugh said. And “[t]his would undoubtedly lead to further cannabis abuse.